Suppr超能文献

人口统计学调整后的 HIV 痴呆量表的预测效度。

Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.

机构信息

Joint Doctoral Program in Clinical Psychology, San Diego State University and University of California San Diego, San Diego, CA 92103, USA.

出版信息

J Clin Exp Neuropsychol. 2008 Jan;30(1):83-90. doi: 10.1080/13803390701233865. Epub 2007 Apr 20.

Abstract

The aim of the current study was to develop and validate demographically adjusted normative standards for the HIV Dementia Scale (HDS). Given the association between demographic variables and the HDS summary score, demographically adjusted normative standards may enhance the classification accuracy of the HDS. Demographically adjusted normative standards were derived from a sample of 182 seronegative healthy participants and were subsequently applied to a sample of 135 HIV-1 seropositive individuals with multidisciplinary case conference diagnoses of HIV-1-associated neurocognitive disorders (e.g., HIV-1-associated dementia and minor-cognitive/motor disorder) in proportions consistent with published epidemiologic reports. In the normative sample, age and education (and their interaction) emerged as the only demographic factors significantly associated with the HDS. In comparison to the traditional HDS cut score (raw score total <or=10), use of the demographically adjusted normative standards significantly improved the sensitivity (from 17.2% to 70.7%, respectively) and overall classification accuracy (increasing the odds ratio from 3 to approximately 6) of the HDS for identifying participants with HIV-1-associated neurocognitive disorders. The application of demographically adjusted normative standards on the HDS improves the clinical applicability and accuracy of this cognitive screening measure in the detection of HIV-1-associated neurocognitive disorders.

摘要

本研究旨在制定并验证经过人口统计学调整的 HIV 痴呆量表(HDS)的常模标准。鉴于人口统计学变量与 HDS 总分之间存在关联,因此经过人口统计学调整的常模标准可能会提高 HDS 的分类准确性。经过人口统计学调整的常模标准源于 182 名血清阴性健康参与者的样本,随后将其应用于 135 名 HIV-1 血清阳性个体的样本中,这些个体通过多学科病例会议诊断患有 HIV-1 相关神经认知障碍(如 HIV-1 相关痴呆和轻微认知/运动障碍),其比例与已发表的流行病学报告一致。在常模样本中,年龄和教育(及其相互作用)是唯一与 HDS 显著相关的人口统计学因素。与传统的 HDS 截断分数(原始分数总和<或=10)相比,使用经过人口统计学调整的常模标准显著提高了 HDS 识别 HIV-1 相关神经认知障碍患者的敏感性(分别从 17.2%提高到 70.7%)和总体分类准确性(将优势比从 3 提高到约 6)。在 HDS 中应用经过人口统计学调整的常模标准可提高该认知筛查工具在检测 HIV-1 相关神经认知障碍方面的临床适用性和准确性。

相似文献

1
Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.
J Clin Exp Neuropsychol. 2008 Jan;30(1):83-90. doi: 10.1080/13803390701233865. Epub 2007 Apr 20.
2
The HIV Dementia Scale: predictive power in mild dementia and HAART.
J Neurol Sci. 2007 Sep 15;260(1-2):11-5. doi: 10.1016/j.jns.2006.03.023. Epub 2007 May 4.
3
Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
J Clin Exp Neuropsychol. 2017 Oct;39(8):753-767. doi: 10.1080/13803395.2016.1263282. Epub 2017 Jan 4.
4
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.
J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):36-42. doi: 10.1097/QAI.0b013e318278ffa4.
6
Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders.
J Clin Exp Neuropsychol. 2013;35(1):1-8. doi: 10.1080/13803395.2012.733682. Epub 2012 Nov 1.
7
Validity of two scales in identifying HIV-associated dementia.
J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):134-40.

引用本文的文献

1
Ethnic Differences in the Association Between Cognitive Performance and Informant-rated Cognitive Decline.
Am J Geriatr Psychiatry. 2025 Jun;33(6):664-677. doi: 10.1016/j.jagp.2024.12.003. Epub 2024 Dec 15.
2
Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.
Curr Top Behav Neurosci. 2021;50:429-478. doi: 10.1007/7854_2019_117.
6
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.
J Neurol. 2017 Aug;264(8):1715-1727. doi: 10.1007/s00415-017-8503-2. Epub 2017 May 31.

本文引用的文献

1
Clinical discriminations and neuropsychological tests: An appeal to bayes' theorem.
Clin Neuropsychol. 1993 Apr;7(2):224-233. doi: 10.1080/13854049308401527.
2
Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment.
AIDS. 2006 Apr 4;20(6):879-87. doi: 10.1097/01.aids.0000218552.69834.00.
4
HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS.
J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):185-91. doi: 10.1176/jnp.17.2.185.
5
Initial validation of a screening battery for the detection of HIV-associated cognitive impairment.
Clin Neuropsychol. 2004 May;18(2):234-48. doi: 10.1080/13854040490501448.
6
HIV dementia: an evolving disease.
J Neuroimmunol. 2004 Dec;157(1-2):3-10. doi: 10.1016/j.jneuroim.2004.08.042.
7
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
J Clin Exp Neuropsychol. 2004 Sep;26(6):759-78. doi: 10.1080/13803390490509565.
8
CLINICAL NEUROPSYCHOLOGY.
Med Clin North Am. 1963 Nov;47:1647-58.
9
Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale.
J Acquir Immune Defic Syndr. 2003 May 1;33(1):116-8. doi: 10.1097/00126334-200305010-00018.
10
Validity of two scales in identifying HIV-associated dementia.
J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):134-40.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验